Broucek Joseph R, Sanford Dominic, Stauffer John A, Asbun Horacio J
Department of Surgery, Vanderbilt University Medical Center, 1161 21st Avenue South, D5203 MCN, Nashville, TN 37232, USA; Department of General Surgery, Mayo Clinic, Davis 3N, 4500 San Pablo Road, Jacksonville, FL 32224, USA.
Department of General Surgery, Mayo Clinic, Davis 3N, 4500 San Pablo Road, Jacksonville, FL 32224, USA; Department of Surgery, Washington University School of Medicine, Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plaza, St. Louis, MO 63110, USA.
Surg Oncol Clin N Am. 2019 Apr;28(2):255-272. doi: 10.1016/j.soc.2018.11.006. Epub 2019 Feb 10.
In pancreatic cancer, resection combined with neoadjuvant and/or adjuvant therapy remains the only chance for cure and/or prolonged survival. A minimally invasive approach to pancreatic cancer has gained increased acceptance and popularity. The aim of minimally invasive surgery of the pancreas includes limiting trauma, decreasing length of hospitalization, lessening cost, decreasing blood loss, and allowing for a more meticulous oncologic dissection. New advances and routine use in practice have helped progress the field making the minimally invasive approach more feasible. In this article, the minimally invasive surgical approaches to proximal, central, and distal pancreatic cancer are described and literature reviewed.
在胰腺癌中，手术切除联合新辅助和/或辅助治疗仍然是治愈和/或延长生存期的唯一机会。胰腺癌的微创治疗方法已越来越被接受和普及。胰腺微创手术的目的包括减少创伤、缩短住院时间、降低费用、减少失血，并允许进行更精细的肿瘤解剖。该领域的新进展和在实践中的常规应用推动了其发展，使微创治疗方法更可行。本文描述了胰腺癌近端、中部和远端的微创外科手术方法并对文献进行了综述。
